T. Rowe Price Investment Management’s Ascendis Pharma ASND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $530M | Sell |
|
|||||
|
2025
Q2 | $619M | Buy |
|
|||||
|
2025
Q1 | $476M | Buy |
|
|||||
|
2024
Q4 | $375M | Buy |
|
|||||
|
2024
Q3 | $264M | Buy |
|
|||||
|
2024
Q2 | $4.17M | Sell |
|
|||||
|
2024
Q1 | $388M | Sell |
|
|||||
|
2023
Q4 | $503M | Buy |
|
|||||
|
2023
Q3 | $373M | Buy |
|
|||||
|
2023
Q2 | $355M | Buy |
|
|||||
|
2023
Q1 | $372M | Buy |
|
|||||
|
2022
Q4 | $345M | Buy |
|
|||||
|
2022
Q3 | $210M | Buy |
|